We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
42 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YESINTEK ustekinumab 45 mg/0.5 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YESINTEK ustekinumab 130 mg/26 mL solution for intravenous infusion injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YESINTEK ustekinumab 90 mg/1 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YESINTEK ustekinumab 45 mg/0.5 mL solution for injection vial.
-
Prescription medicine decision summaryYesintek is approved for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis in adults, and plaque psoriasis in children aged 6 years and older.
-
-
Dec-2025Prescription medicine evaluationActive ingredient: dexrazoxane.
-
-
-
Cancellation by sponsorRequested by Maxx Pharma Pty Ltd